Results 1 to 10 of about 11,974 (182)

Combined Effects of Diazoxide and Moderate-Intensity Exercise on the Restoration of Redox Balance Post-Fatigue in Fast- and Slow-Twitch Skeletal Muscles of Hypertensive Rats [PDF]

open access: yesBiology
Muscle fatigue, defined as a decline in force generation, is closely linked to redox imbalance—a condition exacerbated by oxidative stress in hypertension. This study investigated the effects of diazoxide administration and moderate-intensity exercise on
Estefanía Bravo-Sánchez   +10 more
doaj   +2 more sources

Real-world experience with the use of diazoxide among people living with congenital hyperinsulinism and their caregivers [PDF]

open access: yesFrontiers in Endocrinology
IntroductionCongenital hyperinsulinism (HI) is a rare disease that causes severe hypoglycemia. Diazoxide is the first-line treatment; however, many individuals using diazoxide continue to experience hypoglycemia. Diazoxide is associated with side effects
Tai L. S. Pasquini   +8 more
doaj   +2 more sources

Trisomy 13 as a risk factor for pulmonary hypertension induced by diazoxide [PDF]

open access: yesAnnals of Pediatric Cardiology
Introduction: Diazoxide has been used globally for hyperinsulinemic hypoglycemia. However, serious adverse drug reactions, such as pulmonary hypertension (PH), are major concerns.
Kazu Ishikawa   +4 more
doaj   +2 more sources

Identification of an ABCC8 variant in a kindred with transient diazoxide responsive hyperinsulinism [PDF]

open access: yesEndocrinology, Diabetes & Metabolism Case Reports
Congenital hyperinsulinism is a rare disorder characterized by hypoglycemia and inappropriately elevated insulin levels. The genetics of congenital hyperinsulinism is complex, with the most common cause being pathogenic variants in the ATP-sensitive ...
Ryan L Smith, Stephen I Stone
doaj   +2 more sources

Case Report: Diazoxide-induced diabetic ketoacidosis in a patient with insulinoma [PDF]

open access: yesFrontiers in Endocrinology
Definitive management of insulinoma is challenging as curative surgery is associated with a considerable risk of morbidity and mortality. The successful long-term use of diazoxide for patients diagnosed with insulinoma has been described, but rarely, the
Run Ting Chin   +3 more
doaj   +2 more sources

Severe transient neonatal hyperinsulinism: First Peruvian case series [PDF]

open access: yesSAGE Open Medical Case Reports
Congenital hyperinsulinism is characterized by dysregulated insulin secretion and is the most common and severe cause of persistent hypoglycemia in pediatrics. Brain damage rates can be as high as 50% due to inadequate treatment.
Manuel André Virú-Loza   +2 more
doaj   +2 more sources

Development and clinical application of a stability-indicating chromatography technique for the quantification of diazoxide

open access: yesHeliyon, 2023
Diazoxide is a potential candidate for the treatment of transitional hypoglycaemia in infants. A clinical trial is currently underway to investigate whether low-dose oral diazoxide is beneficial for severe or recurrent transitional neonatal hypoglycaemia
Trusha J. Purohit   +4 more
doaj   +1 more source

Diazoxide is a powerful cardioprotectant but is not feasible in a realistic infarct scenario

open access: yesFrontiers in Cardiovascular Medicine, 2023
IntroductionDiazoxide is a powerful cardioprotective agent that activates mitochondrial ATP-dependent K-channels and stimulates mitochondrial respiration.
Petra Kleinbongard   +3 more
doaj   +1 more source

Diazoxide-Induced Hypertrichosis in a Neonate With Transient Hyperinsulinism

open access: yesClinical Medicine Insights: Case Reports, 2023
Diazoxide is one of the FDA-approved pharmacologic treatments for hyperinsulinemic hypoglycemia, however, its adverse effects in infants are not well described. We reported a 37-week-old boy with the diagnosis of hypoglycemia.
Seyyed Javad Boskabadi   +3 more
doaj   +1 more source

Diazoxide Post-conditioning Activates the HIF-1/HRE Pathway to Induce Myocardial Protection in Hypoxic/Reoxygenated Cardiomyocytes

open access: yesFrontiers in Cardiovascular Medicine, 2021
Background: Previous studies have shown that diazoxide can protect against myocardial ischemia-reperfusion injury (MIRI). The intranuclear hypoxia-inducible factor-1 (HIF-1)/hypoxia-response element (HRE) pathway has been shown to withstand cellular ...
Xi-Yuan Chen   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy